Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Age- and gender-related differences in brain tissue microstructure revealed by multi-component T2 relaxometry.
Canales-Rodríguez EJ, Alonso-Lana S, Verdolini N, Sarró S, Feria I, Montoro I, Garcia-Ruiz B, Jimenez E, Varo C, Albacete A, Argila-Plaza I, Lluch A, Bonnin CM, Vilella E, Vieta E, Pomarol-Clotet E, Salvador R. Canales-Rodríguez EJ, et al. Among authors: lluch a. Neurobiol Aging. 2021 Oct;106:68-79. doi: 10.1016/j.neurobiolaging.2021.06.002. Epub 2021 Jun 10. Neurobiol Aging. 2021. PMID: 34252873 Free article.
Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines.
Martin M, Spielmann M, Namer M, duBois A, Unger C, Dodwell D, Vodvarka P, Lind M, Calvert H, Casado A, Zelek L, Lluch A, Carrasco E, Kayitalire L, Zielinski C. Martin M, et al. Among authors: lluch a. Ann Oncol. 2003 Aug;14(8):1246-52. doi: 10.1093/annonc/mdg339. Ann Oncol. 2003. PMID: 12881387 Free article. Clinical Trial.
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen.
Martín M, Lluch A, Seguí MA, Ruiz A, Ramos M, Adrover E, Rodríguez-Lescure A, Grosse R, Calvo L, Fernandez-Chacón C, Roset M, Antón A, Isla D, del Prado PM, Iglesias L, Zaluski J, Arcusa A, López-Vega JM, Muñoz M, Mel JR. Martín M, et al. Among authors: lluch a. Ann Oncol. 2006 Aug;17(8):1205-12. doi: 10.1093/annonc/mdl135. Epub 2006 Jun 9. Ann Oncol. 2006. PMID: 16766587 Free article. Clinical Trial.
429 results